| 26.3 0.13 (0.5%) | 12-15 15:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 33.11 | 1-year : | 38.67 |
| Resists | First : | 28.35 | Second : | 33.11 |
| Pivot price | 25.47 |
|||
| Supports | First : | 24.65 | Second : | 22.37 |
| MAs | MA(5) : | 25.44 |
MA(20) : | 25.49 |
| MA(100) : | 22.25 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 60.3 |
D(3) : | 49.1 |
| RSI | RSI(14): 56.8 |
|||
| 52-week | High : | 30 | Low : | 13.25 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ KMTS ] has closed below upper band by 24.3%. Bollinger Bands are 5.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 27.21 - 27.31 | 27.31 - 27.4 |
| Low: | 24.07 - 24.19 | 24.19 - 24.28 |
| Close: | 26.03 - 26.23 | 26.23 - 26.38 |
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
Sat, 13 Dec 2025
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Up - Here's What Happened - MarketBeat
Sat, 13 Dec 2025
Wells Fargo Maintains Kestra Medical Technologies (KMTS) Overweight Recommendation - Nasdaq
Sat, 13 Dec 2025
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Thu, 11 Dec 2025
Kestra Medical (KMTS) Q2 2026 Earnings Transcript - The Globe and Mail
Thu, 11 Dec 2025
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC 10-Q Report - TradingView — Track All Markets
Thu, 11 Dec 2025
Kestra Medical Technologies plunges 11% as quarterly loss exceeds estimates - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 58 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 5.5 (%) |
| Held by Institutions | 84.6 (%) |
| Shares Short | 1,950 (K) |
| Shares Short P.Month | 1,640 (K) |
| EPS | -3.97 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.19 |
| Profit Margin | -178 % |
| Operating Margin | -140.8 % |
| Return on Assets (ttm) | -44 % |
| Return on Equity (ttm) | -126.5 % |
| Qtrly Rev. Growth | 53.4 % |
| Gross Profit (p.s.) | 0.59 |
| Sales Per Share | 1.27 |
| EBITDA (p.s.) | -2.08 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -87 (M) |
| Levered Free Cash Flow | -72 (M) |
| PE Ratio | -6.78 |
| PEG Ratio | 0 |
| Price to Book value | 8.4 |
| Price to Sales | 21.06 |
| Price to Cash Flow | -18.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|